Literature DB >> 25567580

Cocrystals of the antibiotic trimethoprim with glutarimide and 3,3-dimethylglutarimide held together by three hydrogen bonds.

Quoc Cuong Ton1, Ernst Egert1.   

Abstract

The antibiotic trimethoprim [5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine] was cocrystallized with glutarimide (piperidine-2,6-dione) and its 3,3-dimethyl derivative (4,4-dimethylpiperidine-2,6-dione). The cocrystals, viz. trimethoprim-glutarimide (1/1), C14H18N4O3·C5H7NO2, (I), and trimethoprim-3,3-dimethylglutarimide (1/1), C14H18N4O3·C7H11NO2, (II), are held together by three neighbouring hydrogen bonds (one central N-H...N and two N-H...O) between the pyrimidine ring of trimethoprim and the imide group of glutarimide, with an ADA/DAD pattern (A = acceptor and D = donor). These heterodimers resemble two known cocrystals of trimethoprim with barbituric acid and its 5,5-diethyl derivative. Trimethoprim shows a conformation in which the planes of the pyrimidine and benzene rings are approximately perpendicular to one another. In its glutarimide coformer, five of the six ring atoms lie in a common plane; the C atom opposite the N atom deviates by about 0.6 Å. The crystal packing of each of the two cocrystals is characterized by an extended network of hydrogen bonds and contains centrosymmetrically related trimethoprim homodimers formed by a pair of N-H...N hydrogen bonds. This structural motif occurs in five of the nine published crystal structures in which neutral trimethoprim is present.

Entities:  

Keywords:  active pharmaceutical ingredients; antibiotics; cocrystal; crystal structure; glutarimide; hydrogen bonds; molecular recognition; trimethoprim

Mesh:

Substances:

Year:  2015        PMID: 25567580     DOI: 10.1107/S2053229614027193

Source DB:  PubMed          Journal:  Acta Crystallogr C Struct Chem        ISSN: 2053-2296            Impact factor:   1.172


  2 in total

1.  Dihydrofolate Reductase Inhibitors: The Pharmacophore as a Guide for Co-Crystal Screening.

Authors:  João A Baptista; Mário T S Rosado; Ricardo A E Castro; António O L Évora; Teresa M R Maria; Manuela Ramos Silva; João Canotilho; M Ermelinda S Eusébio
Journal:  Molecules       Date:  2021-11-06       Impact factor: 4.411

2.  Differences in Coformer Interactions of the 2,4-Diaminopyrimidines Pyrimethamine and Trimethoprim.

Authors:  Lamis Alaa Eldin Refat; Ciaran O'Malley; John M Simmie; Patrick McArdle; Andrea Erxleben
Journal:  Cryst Growth Des       Date:  2022-04-08       Impact factor: 4.010

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.